In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Senate FDA reform bill floor amendments discouraged by Labor Committee policy advisor.

This article was originally published in The Rose Sheet

Executive Summary

FDA REFORM LEGISLATION FLOOR AMENDMENTS SHOULD NOT BE PURSUED, Senate Labor & Human Resources Committee Health Policy Advisor Jane Williams said, warning that this tactic could kill Sen. Nancy Kassebaum's (R-Kan.) FDA reform legislation (S 1477). Speaking at a May 13 Food & Drug Law Institute Pharmaceutical update meeting in Washington, D.C., Williams asserted that because of the limited time left in this session, the bill will never reach the floor if too many time-consuming amendments are filed.



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts